Ripple Era ETFs Record First Red Week Amid Market Rotation
XRP ETFs posted their first weekly red bar after months of inflows, while Bitcoin and Ethereum ETFs logged solid gain...
Ways To Earn Cash Today Without Spending
Want to earn cash today without spending a dime? Discover effective strategies that allow you to generate income quickly.
25,920 articlesPrice Prediction: Nvidia Stock Could Double This Year
Nvidia stock sits at a crossroads as AI demand sustains rapid growth. A new price prediction assesses the odds of a d...
Ethereum Price Analysis: Is $2K Next After Support Reclaim
Ethereum recaptured a key support level and is testing the path toward $2,000. Traders are watching whether a breakou...
Employee Revolt Once Forced Google to Back Off—Then and Now
Google moves forward on a Pentagon AI deal while roughly six hundred staffers sign a protest letter. The era of stron...
CFPB Costs in Debate Over Unsecured Loans for Consolidation
A fresh Council of Economic Advisers report challenges the net cost figures tied to CFPB rules, arguing higher rates ...
AXT Inc Set to Report Earnings After a 1,000% Rally
AXT Inc. is poised for a pivotal earnings night after a dramatic rally. Look for updates on demand for indium phosphi...
Bitcoin Bloodbath: $370M Liquidations Shock Markets
Bitcoin faces a sharp deleveraging as more than $370 million in liquidations hit long bets, while corporate buyers mo...
Best Real Estate Apps for Agents in 2026: Top Tools
In 2026, real estate agents increasingly rely on mobile tools to manage leads, market listings, and discuss loan opti...
Saylor’s Strategy Spends Over $200M to Buy 3,015 BTC
A fresh purchase adds 3,015 BTC for about $204.1 million, lifting total holdings to 720,737 BTC. BTC sits near $66,00...
RESPA Uncertainty Turns Referrals: A New Legal Battleground
Regulatory uncertainty over RESPA is transforming agent referrals into a legal battleground, pushing lenders and brok...
Price Analysis: Ethereum Risks Dropping Below 2K Again
Ethereum faces renewed downside risk as momentum wanes. Traders watch $2,150 on the near term and a crucial $2,000 le...
UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status